Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality.
J. Gould, M. Kliś, B. Porter, B. Sieniewicz, B. Sidhu, S. Claridge, Steven E. Williams, A. Shetty, M. O'Neill, J. Gill, C. Rinaldi
Europace